Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel.

Abstract

Vitamin D (VITD) is a key hormone for bone health and has relevant extra-skeletal effects that might play a role in the prevention and treatment of COronaVIrus Disease 19 (COVID-19). Literature regarding this scenario is voluminous but controversial. Glucocorticoid Induced Osteoporosis Skeletal Endocrinology Group (G.I.O.S.E.G) has been present in the scientific debate about the use of VITD and has regularly interfaced national regulatory agencies to ensure appropriateness of its employment. Given the current pandemic and the questions on COVID-19 and VITD, G.I.O.S.E.G. appointed an expert panel to advise how to consider this issue best. The results of these deliberations are reported in the current recommendation paper.

• Authors: Fabio Massimo Ulivieri, Giuseppe Banfi, Valentina Camozzi, Annamaria Colao, Anna Maria Formenti, Stefano Frara, Giovanni Lombardi, Nicola Napoli, Andrea Giustina
• Journal: Endocrine (Endocrine) Vol. 72 Issue 3 Pg. 597-603 (06 2021) ISSN: 1559-0100 [Electronic] United States
• PMID: 33999367 (Publication Type: Journal Article, Review)

Chemical References

• Vitamins
• Vitamin D

Topics

• COVID-19
• Humans
• Pandemics
• SARS-CoV-2
• Vitamin D
• Vitamins